ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells

Wang, Jinxiang; Zeng, Leli; Wu, Nisha; Liang, Yanling; Jin, Jie; Fan, Mingming; Lai, Xiaoju; Chen, Zhe-Sheng; Pan, Yihang*; Zeng, Fangyin*; Deng, Fan*南方医科大学; 中山大学; 5
DRUG RESISTANCE UPDATES2023-9DOI: 10.1016/j.drup.2023.100985
2被引5阅读
引用收藏
分享

摘要

Phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme in the first step of the serine synthesis pathway (SSP), is overexpressed in multiple types of cancers. The androgen receptor inhibitor enzalutamide (Enza) is the primary therapeutic drug for patients with castration-resistant prostate cancer (CRPC). However, most patients eventually develop resistance to Enza. The association of SSP with Enza resistance remains unclear. In this study, we found that high expression of PHGDH was associated with Enza resistance in CRPC cells. Moreover, increased expression of PHGDH led to ferroptosis resistance by maintaining redox homeostasis in Enza-resistant CRPC cells. Knockdown of PHGDH caused significant GSH reduction, induced lipid peroxides (LipROS) increase and significant cell death, resulting in inhibiting growth of Enza-resistant CRPC cells and sensitizing Enza-resistant CRPC cells to enzalutamide treatment both in vitro and in vivo. We also found that overexpression of PHGDH promoted cell growth and Enza resistance in CRPC cells. Furthermore, pharmacological inhibition of PHGDH by NCT-503 effectively inhibited cell growth, induced ferroptosis, and overcame enzalutamide resistance in Enza-resistant CRPC cells both in vitro and in vivo. Mechanically, NCT-503 triggered ferroptosis by decreasing GSH/GSSG levels and increasing LipROS production as well as suppressing SLC7A11 expression through activation of the p53 signaling pathway. Moreover, stimulating ferroptosis by ferroptosis inducers (FINs) or NCT-503 synergistically sensitized Enza-resistant CRPC cells to enzalutamide. The synergistic effects of NCT-503 and enzalutamide were verified in a xenograft nude mouse model. NCT-503 in combination with enzalutamide effectively restricted the growth of Enza-resistant CRPC xenografts in vivo. Overall, our study highlights the essential roles of increased PHGDH in mediating enzalutamide resistance in CRPC. Therefore, the combination of ferroptosis inducer and targeted inhibition of PHGDH could be a potential therapeutic strategy for overcoming enzalutamide resistance in CRPC.

学科与关键词

关键词
CRPCPHGDHEnzalutamide resistanceFerroptosisRedox homeostasis
相关
加载中…
  • Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer
    Zhou, Xumin; Zou, Libin; Chen, Wenbin; Yang, Taowei; Luo, Junqi; Wu, Kaihui; Shu, Fangpeng; Tan, Xiao; Yang, Yu; Cen, Shengren; Li, Chuanyin*; Mao, Xiangming*Pharmacological Research, 2021, 164: 105305.被引 41
  • Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122
    Cong, Xiaonan; He, Yundong; Wu, Haigang; Wang, Dingxiang; Liu, Yongrui; Shao, Ting; Liu, Mingyao; Yi, Zhengfang; Zheng, Jianghua; Peng, Shihong*; Ding, Tao*Frontiers in Oncology, 2021, 11: 650919.被引 4
  • IU1 and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer
    Zhang, Yifan; Liao, Yuanpeng; Luo, Mayao; Ye, Yuedian; Xu, Zhuofan; Hou, Wenli; Liu, Ruiyu; Zhai, Qiliang; Lv, Shidong*; Wei, Qiang*PROSTATE, 2023, 83(15): 1446-1457.
查看全部 →

发表信息

论文状态
公开发表
期刊
DRUG RESISTANCE UPDATES
发表日期
2023-09
卷期
第 70 卷
页码
100985
DOI
10.1016/j.drup.2023.100985
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81772761, 81672540, 32270815]; National Key Research and Development Program of China [2018YFA0902801]; Science and Technology Foundation of Guangzhou in China [202102080508]; Guangdong Basic and Applied Basic Research Foundation [2022A1515012300, 2021A1515010117]; Guangdong Provincial Key Laboratory of Digestive Cancer Research [2021B1212040006]

作者

  • W

    Wang, Jinxiang (第一作者)

    sun yat sen univ · southern med univ

  • Z

    Zeng, Leli

    sun yat sen univ

查看全部 11 位作者收起作者
  • W

    Wu, Nisha

    5 · southern med univ

  • L

    Liang, Yanling

    5 · southern med univ

  • J

    Jin, Jie

    5 · southern med univ

  • F

    Fan, Mingming

    southern med univ

  • L

    Lai, Xiaoju

    southern med univ

  • C

    Chen, Zhe-Sheng

  • P

    Pan, Yihang (通讯)

    sun yat sen univ

  • Z

    Zeng, Fangyin (通讯)

    5 · southern med univ

  • D

    Deng, Fan (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417